121 results on '"Baron, Ekaterina"'
Search Results
2. Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection
3. Risk factors of a positive resection margin in locoregional appendix cancer and its impact on survival: The national cancer database analysis
4. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
5. Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study
6. Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC
7. ASO Visual Abstract: Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
8. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
9. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases
10. ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC—A Propensity Score-Matched Study
11. Robotic Resection in Succinate Dehydrogenase Subunit B (SDHB)-Mutated Hereditary Paraganglioma: A Case Report of Two Patients and A Literature Review
12. ASO Author Reflections: CRS/HIPEC Cannot be Done—Now what? Systemic Chemotherapy in Mucinous Appendiceal Cancer
13. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
14. Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
15. Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis
16. ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
17. Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancer
18. ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
19. ASO Visual Abstract: Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy With and Without Diaphragmatic Resection in Patients with Peritoneal Metastases
20. Educational Collaboration Between Russian-Born US Physicians and Russian Oncology Trainees in Evidence-Based Medicine: The Higher School of Oncology
21. ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients With Intrapleural Dissemination of Peritoneal Surface Malignancies
22. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma
23. ASO Author Reflections: Is CRS/HIPEC an Indication to Divert Rectal Anastomosis?
24. ASO Author Reflections: When Laboratories Could Help Avoid Unnecessary Surgery
25. Patterns of Recurrence of Mucinous Appendiceal Cancer after Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
26. Recurrence Patterns of Mucinous Appendiceal Cancer after Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
27. Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
28. Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study
29. EP201/#565 Patterns of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy in ovarian cancer patients with neoadjuvant chemotherapy or upfront surgery
30. Reply to: Letter to editor – “Rare, but severe: Delayed Genitoscrotal necrosis after HIPEC with Mitomycin-C″
31. Safety of Nephrectomy Performed during CRS/HIPEC: A Propensity Score Matched Study
32. A Proposed ABCD Classification for Reporting Complications after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
33. Defining ‘High’ PCI as a Prognostic Factor in Appendiceal Cancer Patients Treated with CRS/HIPEC
34. Value of Diagnostic Laparoscopy in Appendiceal Cancer Patient Selection for CRS/HIPEC
35. Impact of Clinical Factors on Survival Outcomes after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendiceal Cancer
36. Association of Preoperative C-reactive protein with Survival in Different Histologies of Mucinous Appendiceal Cancer
37. Patterns of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy in ovarian cancer patients with neoadjuvant chemotherapy or upfront surgery
38. Controlling Perfusion Temperature Relates to Better Outcomes after CRS/HIPEC
39. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases
40. Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C
41. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies
42. Survival Outcomes of Adjuvant Chemotherapy in Stage IVA/B High-grade Appendiceal Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy CRS/HIPEC)
43. Peritoneal dissemination from ovarian carcinosarcoma: Analysis of 14 cases after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
44. Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Carcinomatosis
45. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Tumors of the Appendix
46. Survival Outcomes following Systemic Chemotherapy in Stage IVA/B High-grade Mucinous Appendiceal Cancer after Unsuccessful Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
47. Small Bowel Involvement Topography and Success of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancies
48. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies
49. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience
50. Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.